Problematic Dichotomization of Risk for Intensive Care Unit (ICU)–Acquired Invasive Candidiasis: Results Using a Risk-Predictive Model to Categorize 3 Levels of Risk From a Multicenter Prospective Cohort of Australian ICU Patients
Author(s) -
E. Geoffrey Playford,
Jeffrey Lipman,
Michael Jones,
Anna F. Lau,
Masrura Kabir,
Sharon C.A. Chen,
Deborah Marriott,
Ian Seppelt,
Thomas Gottlieb,
Winston Cheung,
Jonathan R. Iredell,
Emma S. McBryde,
Tania C. Sorrell
Publication year - 2016
Publication title -
clinical infectious diseases
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 3.44
H-Index - 336
eISSN - 1537-6591
pISSN - 1058-4838
DOI - 10.1093/cid/ciw610
Subject(s) - medicine , intensive care unit , intensive care medicine , risk assessment , prospective cohort study , invasive candidiasis , cohort study , cohort , predictive value of tests , risk factor , emergency medicine , antifungal , computer security , fluconazole , dermatology , computer science
Delayed antifungal therapy for invasive candidiasis (IC) contributes to poor outcomes. Predictive risk models may allow targeted antifungal prophylaxis to those at greatest risk.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom